Lee Scott Golden
Director · Cadrenal Therapeutics, Inc.
IndividualSelling only6 10b5-1 trades
- 2025
- Oct 13, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lee Scott Golden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Quang X. Pham - $423K in CVKD purchases and sales in the last 12 months
- Matthew K. Szot - $120K in CVKD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lee Scott Golden?
Lee Scott Golden is a corporate insider, tracked as Director of Cadrenal Therapeutics, Inc. (CVKD). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lee Scott Golden submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Lee Scott Golden been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.12M) across all tracked filings.
